Content about UCLA

February 12, 2013
Teva appoints UCLA urologic oncology professor to board

Teva Pharmaceutical Industries has added a University of California at Los Angeles medical professor to its board of directors, the Israeli drug maker said.

JERUSALEM — Teva Pharmaceutical Industries has added a University of California at Los Angeles medical professor to its board of directors, the Israeli drug maker said.

Teva announced the appointment of Arie Belldegrun, who is a director at the UCLA Institute of Urology Oncology and professor and chair of urologic oncology at the David Geffen School of Medicine. The company appointed Belldegrun at its Feb. 5 meeting to fill a vacancy, and Belldegrun's term will extend the drug maker's 2013 annual shareholder meeting.

July 25, 2012
MinuteClinic forms clinical collaboration with UCLA Health System

MinuteClinic has entered into a clinical affiliation with the UCLA Health System to enhance patient access to high-quality, affordable healthcare services in Los Angeles County.

WOONSOCKET, R.I., and LOS ANGELES — MinuteClinic has entered into a clinical affiliation with the UCLA Health System to enhance patient access to high-quality, affordable healthcare services in Los Angeles County.

September 21, 2011
UCLA researchers find possible link between diabetes drugs, pancreatic cancer

Researchers at the University of California Los Angeles said they have found a possible link between two new drugs for Type 2 diabetes and cancers of the pancreas and thyroid, according to a new study published in the journal Gastroenterology.

LOS ANGELES — Researchers at the University of California Los Angeles said they have found a possible link between two new drugs for Type 2 diabetes and cancers of the pancreas and thyroid, according to a new study published in the journal Gastroenterology.

The researchers, at UCLA's Larry L. Hillblom Islet Research Center, examined incidents reported in the Food and Drug Administration's adverse event database between 2004 and 2009 among patients using Byetta (exenatide), made by Eli Lilly and Amylin Pharmaceuticals, and Merck's Januvia (sitagliptin).

March 23, 2011
EIF Revlon Run/Walk event to be held next month

The 14th annual EIF Revlon Run/Walk for Women in New York is just around the corner, and once again Nate Berkus, host of "The Nate Berkus Show"; Jimmy Fallon, host of "Late Night with Jimmy Fallon"; and Dr. Oz, host of "The Dr. Oz Show," will host the April 30 event, according to beauty company Revlon, the Entertainment Industry Foundation and Lilly Tartikoff, co-founder of the event and co-founder of the Revlon/UCLA Women's Cancer Research program.

LOS ANGELES — The 14th annual EIF Revlon Run/Walk for Women in New York is just around the corner, and once again Nate Berkus, host of "The Nate Berkus Show"; Jimmy Fallon, host of "Late Night with Jimmy Fallon"; and Dr. Oz, host of "The Dr. Oz Show," will host the April 30 event, according to beauty company Revlon, the Entertainment Industry Foundation and Lilly Tartikoff, co-founder of the event and co-founder of the Revlon/UCLA Women's Cancer Research program.

Four-time Grammy nominee Keyshia Cole will present a special performance.

January 12, 2011
Puffs spokeswoman educates moms, kids on cough-cold-flu prevention

Puffs, a Procter & Gamble brand, recently brought spokeswoman Tanya Remer Altmann to share tips with mommy bloggers and their children on healthy winter habits.

NEW YORK — Puffs, a Procter & Gamble brand, recently brought spokeswoman Tanya Remer Altmann to share tips with mommy bloggers and their children on healthy winter habits.

Altmann, a UCLA-trained pediatrician, visited New York City indoor child play space Apple Seeds to give out samples of Puffs tissues and to educate children on good hand-washing habits, best tissues to use for those with sore and chapped noses and ways to avoid coughs, colds and flu during the winter.